BDBM50403056 CHEMBL2216827::US10596172, Compound I-342::US10828300, Compound I-342::US11351168, Compound I-342::US9987276, Compound I-342

SMILES CNC(=O)c1cc(Oc2ccc(Nc3ncc(F)c(Nc4cccc(NC(=O)C=C)c4)n3)cc2)ccn1

InChI Key InChIKey=VVLHQJDAUIPZFH-UHFFFAOYSA-N

Data  1 KI  15 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 16 hits for monomerid = 50403056   

TargetTyrosine-protein kinase BTK(Human)
Covalution Pharma

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 1nMAssay Description:Inhibition of BtkMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Covalution Pharma

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 1nMAssay Description:Inhibition of Btk in human Ramos cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetTyrosine-protein kinase ITK/TSK(Human)
Celgene Car

US Patent
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 55nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Covalution Pharma

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 9.5nMAssay Description:Inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2019
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 1.53E+3nMAssay Description:Inhibition of recombinant human N-terminal GST-tagged JAK3 (781 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2019
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 737nMAssay Description:Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2019
Entry Details Article
PubMed
TargetCytoplasmic tyrosine-protein kinase BMX(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of full length recombinant human N-terminal GST-tagged BMX expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2019
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 550nMAssay Description:EGFR (WT) and EGFR (T790M/L858R): The Omnia Assay Protocol for potency assessment against EGFR is performed as described in Example 251 above except ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Covalution Pharma

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Celgene Car

US Patent
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 55nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 550nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Covalution Pharma

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Covalution Pharma

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 100nMAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/10/2022
Entry Details
Go to US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Celgene Car

US Patent
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 550nMAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/10/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
University of Science and Technology of China

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataIC50: 1.00E+3nMAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/10/2022
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Covalution Pharma

Curated by ChEMBL
LigandPNGBDBM50403056(CHEMBL2216827 | US9987276, Compound I-342 | US1059...)
Affinity DataKi:  209nMAssay Description:Reversible inhibition of full length recombinant human N-terminal His tagged BKT expressed in baculovirus infected Sf9 insect cells using poly (Glu,T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2019
Entry Details Article
PubMed